Disc Medicine Statistics
Share Statistics
Disc Medicine has 34.63M
shares outstanding. The number of shares has increased by 16.53%
in one year.
| Shares Outstanding | 34.63M |
| Shares Change (YoY) | 16.53% |
| Shares Change (QoQ) | 16.17% |
| Owned by Institutions (%) | 88.78% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,184 |
| FTD / Avg. Volume | 0.74% |
Short Selling Information
The latest short interest is 3.23M, so 9.33% of the outstanding
shares have been sold short.
| Short Interest | 3.23M |
| Short % of Shares Out | 9.33% |
| Short % of Float | 10.41% |
| Short Ratio (days to cover) | 8.18 |
Valuation Ratios
The PE ratio is -16 and the forward
PE ratio is -8.58.
Disc Medicine's PEG ratio is
-1.01.
| PE Ratio | -16 |
| Forward PE | -8.58 |
| PS Ratio | 0 |
| Forward PS | 3.2 |
| PB Ratio | 3.95 |
| P/FCF Ratio | -18.53 |
| PEG Ratio | -1.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Disc Medicine.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.17,
with a Debt / Equity ratio of 0.07.
| Current Ratio | 21.17 |
| Quick Ratio | 21.17 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.28 |
| Debt / FCF | -0.32 |
| Interest Coverage | -226.78 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,163,372.34 |
| Employee Count | 94 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 355K |
| Effective Tax Rate | -0.33% |
Stock Price Statistics
The stock price has increased by 35.32% in the
last 52 weeks. The beta is 2.78, so Disc Medicine's
price volatility has been higher than the market average.
| Beta | 2.78 |
| 52-Week Price Change | 35.32% |
| 50-Day Moving Average | 46.2 |
| 200-Day Moving Average | 52.88 |
| Relative Strength Index (RSI) | 50.49 |
| Average Volume (20 Days) | 430,055 |
Income Statement
| Revenue | n/a |
| Gross Profit | -156K |
| Operating Income | -129.72M |
| Net Income | -109.36M |
| EBITDA | -108.27M |
| EBIT | -108.43M |
| Earnings Per Share (EPS) | -3.96 |
Full Income StatementBalance Sheet
The company has 192.43M in cash and 30M in
debt, giving a net cash position of 162.43M.
| Cash & Cash Equivalents | 192.43M |
| Total Debt | 30M |
| Net Cash | 162.43M |
| Retained Earnings | -298M |
| Total Assets | 709.27M |
| Working Capital | 686.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -93.93M
and capital expenditures -505K, giving a free cash flow of -94.43M.
| Operating Cash Flow | -93.93M |
| Capital Expenditures | -505K |
| Free Cash Flow | -94.43M |
| FCF Per Share | -3.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
